Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
Cefiderocol is a novel siderophore cephalosporin, which has proven in vitro activity against carbapenem-resistant (CR) Gram-negative pathogens and stability icon track bar f250 towards all carbapenemases.The aim of this study was to describe the first cases of prescriptions and the efficacy of cefiderocol for compassionate use in the 2 months follo